Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 490209, 10 pages
http://dx.doi.org/10.1155/2015/490209
Research Article

Arctigenin, a Potent Ingredient of Arctium lappa L., Induces Endothelial Nitric Oxide Synthase and Attenuates Subarachnoid Hemorrhage-Induced Vasospasm through PI3K/Akt Pathway in a Rat Model

1Department of Surgery, Faculty of Medicine, School of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan
2Division of Neurosurgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan
3Department of Surgery, Kaohsiung Municipal Ta Tung Hospital, Kaohsiung, Taiwan
4Department of Surgery, Kaohsiung Municipal Hsiao Kang Hospital, Kaohsiung, Taiwan

Received 1 May 2015; Accepted 27 May 2015

Academic Editor: Aaron S. Dumont

Copyright © 2015 Chih-Zen Chang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. P. Dreier, S. Major, A. Manning et al., “Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage,” Brain, vol. 132, no. 7, pp. 1866–1881, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Grasso, “An overview of new pharmacological treatments for cerebrovascular dysfunction after experimental subarachnoid hemorrhage,” Brain Research Reviews, vol. 44, no. 1, pp. 49–63, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. A. G. Kolias, J. Sen, and A. Belli, “Pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage: putative mechanisms and novel approaches,” Journal of Neuroscience Research, vol. 87, no. 1, pp. 1–11, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. M. N. Stienen, R. Weisshaupt, J. Fandino et al., “Current practice in neuropsychological outcome reporting after aneurysmal subarachnoid haemorrhage,” Acta Neurochirurgica, vol. 155, no. 11, pp. 2045–2051, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. C.-H. Chou, S. D. Reed, J. S. Allsbrook, J. L. Steele, K. A. Schulman, and M. J. Alexander, “Costs of vasospasm in patients with aneurysmal subarachnoid hemorrhage,” Neurosurgery, vol. 67, no. 2, pp. 345–351, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. E. S. Connolly, A. A. Rabinstein, J. R. Carhuapoma et al., “Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the american heart association/american stroke association,” Stroke, vol. 43, no. 6, pp. 1711–1737, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. K. P. Budohoski, M. Czosnyka, P. Smielewski et al., “Impairment of cerebral autoregulation predicts delayed cerebral ischemia after subarachnoid hemorrhage: a prospective observational study,” Stroke, vol. 43, no. 12, pp. 3230–3237, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. R. P. Ostrowski, A. R. Colohan, and J. H. Zhang, “Molecular mechanisms of early brain injury after subarachnoid hemorrhage,” Neurological Research, vol. 28, no. 4, pp. 399–414, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Sabri, A. Kawashima, J. Ai, and R. L. Macdonald, “Neuronal and astrocytic apoptosis after subarachnoid hemorrhage: a possible cause for poor prognosis,” Brain Research, vol. 1238, pp. 163–171, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Vatter, J. Konczalla, S. Weidauer et al., “Effect of delayed cerebral vasospasm on cerebrovascular endothelin A receptor expression and function,” Journal of Neurosurgery, vol. 107, no. 1, pp. 121–127, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Ansar, P. Vikman, M. Nielsen, and L. Edvinsson, “Cerebrovascular ETB, 5-HT1B, and AT1 receptor upregulation correlates with reduction in regional CBF after subarachnoid hemorrhage,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 293, no. 6, pp. H3750–H3758, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Cahill, J. W. Calvert, I. Solaroglu, and J. H. Zhang, “Vasospasm and p53-induced apoptosis in an experimental model of subarachnoid hemorrhage,” Stroke, vol. 37, no. 7, pp. 1868–1874, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. S. M. D. Mees, A. Algra, W. P. Vandertop et al., “Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial,” The Lancet, vol. 380, no. 9836, pp. 44–49, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Fabender, B. Hodapp, S. Rossol et al., “Endothelin-1 in subarachnoid hemorrhage: an acute-phase reactant produced by cerebrospinal fluid leukocytes,” Stroke, vol. 31, no. 12, pp. 2971–2975, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Ishrat, I. Sayeed, F. Atif, F. Hua, and D. G. Stein, “Progesterone is neuroprotective against ischemic brain injury through its effects on the phosphoinositide 3-kinase/protein kinase B signaling pathway,” Neuroscience, vol. 210, pp. 442–450, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Dimmeler, I. Fleming, B. Fisslthaler, C. Hermann, R. Busse, and A. M. Zeiher, “Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation,” Nature, vol. 399, no. 6736, pp. 601–605, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Endo, C. Nito, H. Kamada, F. Yu, and P. H. Chan, “Reduction in oxidative stress by superoxide dismutase overexpression attenuates acute brain injury after subarachnoid hemorrhage via activation of Akt/glycogen synthase kinase-3β survival signaling,” Journal of Cerebral Blood Flow and Metabolism, vol. 27, no. 5, pp. 975–982, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. E. N. Momin, K. E. Schwab, K. L. Chaichana, R. Miller-Lotan, A. P. Levy, and R. J. Tamargo, “Controlled delivery of nitric oxide inhibits leukocyte migration and prevents vasospasm in haptoglobin 2-2 mice after subarachnoid hemorrhage,” Neurosurgery, vol. 65, no. 5, pp. 937–945, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. M. A. Moro, A. Cárdenas, O. Hurtado, J. C. Leza, and I. Lizasoain, “Role of nitric oxide after brain ischaemia,” Cell Calcium, vol. 36, no. 3-4, pp. 265–275, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. V. Neuschmelting, S. Marbacher, A.-R. Fathi, S. M. Jakob, and J. Fandino, “Elevated level of endothelin-1 in cerebrospinal fluid and lack of nitric oxide in basilar arterial plasma associated with cerebral vasospasm after subarachnoid haemorrhage in rabbits,” Acta Neurochirurgica, vol. 151, no. 7, pp. 795–801, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Yamashiro, A. B. Milsom, J. Duchene et al., “Alterations in nitric oxide and endothelin-1 bioactivity underlie cerebrovascular dysfunction in ApoE-deficient mice,” Journal of Cerebral Blood Flow and Metabolism, vol. 30, no. 8, pp. 1494–1503, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. D. M. Arrick and W. G. Mayhan, “Inhibition of endothelin-1 receptors improves impaired nitric oxide synthase-dependent dilation of cerebral arterioles in type-1 diabetic rats,” Microcirculation, vol. 17, no. 6, pp. 439–446, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. C.-Z. Chang, S.-C. Wu, and A.-L. Kwan, “Magnesium lithospermate B, an active extract of salvia miltiorrhiza, mediates SGC/CGMP/PKG translocation in experimental vasospasm,” BioMed Research International, vol. 2014, Article ID 272101, 9 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Kästner, M. F. Oertel, W. Scharbrodt, M. Krause, D.-K. Böker, and W. Deinsberger, “Endothelin-1 in plasma, cisternal CSF and microdialysate following aneurysmal SAH,” Acta Neurochirurgica, vol. 147, no. 12, pp. 1271–1279, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Xie, Y. Aihara, V. A. Bouryi et al., “Novel mechanism of endothelin-1-induced vasospasm after subarachnoid hemorrhage,” Journal of Cerebral Blood Flow and Metabolism, vol. 27, no. 10, pp. 1692–1701, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Mori, T. Yamamoto, M. Miyazaki et al., “Optimal cerebrospinal fluid magnesium ion concentration for vasodilatory effect and duration after intracisternal injection of magnesium sulfate solution in a canine subarachnoid hemorrhage model: laboratory investigation,” Journal of Neurosurgery, vol. 114, no. 4, pp. 1168–1175, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Sasaki, H. Kasuya, H. Onda et al., “Role of p38 mitogen-activated protein kinase on cerebral vasospasm after subarachnoid hemorrhage,” Stroke, vol. 35, no. 6, pp. 1466–1470, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Vikman, S. Beg, T. Khurana, J. Hansen-Schwartz, and L. Edvinsson, “Gene expression and molecular changes in cerebral arteries following subarachnoid hemorrhage in the rat,” Journal of Neurosurgery, vol. 105, no. 3, pp. 438–444, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. Z. Wang, G. Chen, W.-W. Zhu, and D. Zhou, “Activation of nuclear factor-erythroid 2-related factor 2 (Nrf2) in the basilar artery after subarachnoid hemorrhage in rats,” Annals of Clinical and Laboratory Science, vol. 40, no. 3, pp. 233–239, 2010. View at Google Scholar · View at Scopus
  30. C. Zhou, M. Yamaguchi, G. Kusaka, C. Schonholz, A. Nanda, and J. H. Zhang, “Caspase inhibitors prevent endothelial apoptosis and cerebral vasospasm in dog model of experimental subarachnoid hemorrhage,” Journal of Cerebral Blood Flow and Metabolism, vol. 24, no. 4, pp. 419–431, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Herrera, N. J. Hong, P. A. Ortiz, and J. L. Garvin, “Endothelin-1 Lnhibits thick ascending limb transport via Akt-stimulated nitric oxide production,” The Journal of Biological Chemistry, vol. 284, no. 3, pp. 1454–1460, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Kawasaki, R. S. Smith Jr., C.-M. Hsieh, J. Sun, J. Chao, and J. K. Liao, “Activation of the phosphatidylinositol 3-kinase/protein kinase Akt pathway mediates nitric oxide-induced endothelial cell migration and angiogenesis,” Molecular and Cellular Biology, vol. 23, no. 16, pp. 5726–5737, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. S. R. Datta, A. Brunet, and M. E. Greenberg, “Cellular survival: a play in three akts,” Genes and Development, vol. 13, no. 22, pp. 2905–2927, 1999. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Li, J. Wang, M. Wu, X. Zhang, and H. Zhang, “The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27Kip1 induction by interfering with PI3K/Akt/FOXO3a signaling pathway,” European Journal of Pharmacology, vol. 747, pp. 71–87, 2015. View at Publisher · View at Google Scholar
  35. C. Liu, T. Su, F. Li et al., “PI3K/Akt signaling transduction pathway is involved in rat vascular smooth muscle cell proliferation induced by apelin-13,” Acta Biochimica et Biophysica Sinica, vol. 42, no. 6, pp. 396–402, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. X.-Q. Peng, M. Damarla, J. Skirball et al., “Protective role of PI3-kinase/Akt/eNOS signaling in mechanical stress through inhibition of p38 mitogen-activated protein kinase in mouse lung,” Acta Pharmacologica Sinica, vol. 31, no. 2, pp. 175–183, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. F. Roviezzo, S. Cuzzocrea, A. Di Lorenzo et al., “Protective role of PI3-kinase-Akt-eNOS signalling pathway in intestinal injury associated with splanchnic artery occlusion shock,” British Journal of Pharmacology, vol. 151, no. 3, pp. 377–383, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. J.-P. Gratton, G. Cournoyer, and P. D'Orléans-Juste, “Endothelin-B receptor-dependent modulation of the pressor and prostacyclin-releasing properties of dynamically converted big endothelin-1 in the anesthetized rabbit,” Journal of Cardiovascular Pharmacology, vol. 31, no. 1, pp. S161–S163, 1998. View at Publisher · View at Google Scholar · View at Scopus
  39. M. K. Cho, J. W. Park, Y. P. Jang, Y. C. Kim, and S. G. Kim, “Potent inhibition of lipopolysaccharide-inducible nitric oxide synthase expression by dibenzylbutyrolactone lignans through inhibition of I-kappaBalpha phosphorylation and of p65 nuclear translocation in macrophages,” International Immunopharmacology, vol. 2, no. 1, pp. 105–116, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. Y. P. Jang, S. R. Kim, Y. H. Choi et al., “Arctigenin protects cultured cortical neurons from glutamate-induced neurodegeneration by binding to kainate receptor,” Journal of Neuroscience Research, vol. 68, no. 2, pp. 233–240, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. Jeong, J. Park, D. Kim, and H. Kim, “Arctigenin increases hemeoxygenase-1 gene expression by modulating PI3K/AKT signaling pathway in rat primary astrocytes,” Biomolecules and Therapeutics, vol. 22, no. 6, pp. 497–502, 2014. View at Publisher · View at Google Scholar
  42. H. Liu, Y. Yang, X. Cai, Y. Gao, J. Du, and S. Chen, “The effects of arctigenin on human rheumatoid arthritis fibroblast-like synoviocytes,” Pharmaceutical Biology, vol. 5, pp. 1–6, 2015. View at Publisher · View at Google Scholar
  43. V. Swarup, J. Ghosh, M. K. Mishra, and A. Basu, “Novel strategy for treatment of Japanese encephalitis using arctigenin, a plant lignan,” Journal of Antimicrobial Chemotherapy, vol. 61, no. 3, pp. 679–688, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. T. Fan, W. L. Jiang, J. Zhu, and Y. F. Zhang, “Arctigenin protects focal cerebral ischemia-reperfusion rats through inhibiting neuroinflammation,” Biological and Pharmaceutical Bulletin, vol. 35, no. 11, pp. 2004–2009, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. Z. Zhu, J. Yan, W. Jiang et al., “Arctigenin effectively ameliorates memory impairment in Alzheimer's disease model mice targeting both β-amyloid production and clearance,” Journal of Neuroscience, vol. 33, no. 32, pp. 13138–13149, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. F. Raslan, C. Albert-Weißenberger, T. Westermaier, S. Saker, C. Kleinschnitz, and J.-Y. Lee, “A modified double injection model of cisterna magna for the study of delayed cerebral vasospasm following subarachnoid hemorrhage in rats,” Experimental and Translational Stroke Medicine, vol. 4, no. 1, article 23, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. B. D. Manning and L. C. Cantley, “AKT/PKB signaling: navigating downstream,” Cell, vol. 129, no. 7, pp. 1261–1274, 2007. View at Publisher · View at Google Scholar · View at Scopus